Hartman Institute for Therapeutic Organ Regeneration

A reverse genetic approach to test functional redundancy during embryogenesis.

TitleA reverse genetic approach to test functional redundancy during embryogenesis.
Publication TypeJournal Article
Year of Publication2010
AuthorsRikin A, Rosenfeld GE, McCartin K, Evans T
JournalJ Vis Exp
Issue42
Date Published2010 Aug 11
ISSN1940-087X
KeywordsAnimals, Embryo, Nonmammalian, Embryonic Development, Female, GATA Transcription Factors, GATA5 Transcription Factor, Gene Knockdown Techniques, Male, Oligonucleotides, Antisense, Zebrafish, Zebrafish Proteins
Abstract

<p>Gene function during embryogenesis is typically defined by loss-of-function experiments, for example by targeted mutagenesis (knockout) in the mouse. In the zebrafish model, effective reverse genetic techniques have been developed using microinjection of gene-specific antisense morpholinos. Morpholinos target an mRNA through specific base-pairing and block gene function transiently by inhibiting translation or splicing for several days during embryogenesis (knockdown). However, in vertebrates such as mouse or zebrafish, some gene functions can be obscured by these approaches due to the presence of another gene that compensates for the loss. This is especially true for gene families containing sister genes that are co-expressed in the same developing tissues. In zebrafish, functional compensation can be tested in a relatively high-throughput manner, by co-injection of morpholinos that target knockdown of both genes simultaneously. Likewise, using morpholinos, a genetic interaction between any two genes can be demonstrated by knockdown of both genes together at sub-threshold levels. For example, morpholinos can be titrated such that neither individual knockdown generates a phenotype. If, under these conditions, co-injection of both morpholinos causes a phenotype, a genetic interaction is shown. Here we demonstrate how to show functional redundancy in the context of two related GATA transcription factors. GATA factors are essential for specification of cardiac progenitors, but this is revealed only by the loss of both Gata5 and Gata6. We show how to carry out microinjection experiments, validate the morpholinos, and evaluate the compensated phenotype for cardiogenesis.</p>

DOI10.3791/2020
Alternate JournalJ Vis Exp
PubMed ID20736915
PubMed Central IDPMC3156006
Grant ListR01 HL064282 / HL / NHLBI NIH HHS / United States
R01 HL056182 / HL / NHLBI NIH HHS / United States
HL064282 / HL / NHLBI NIH HHS / United States
HL056182 / HL / NHLBI NIH HHS / United States
R37 HL056182 / HL / NHLBI NIH HHS / United States
T32 HD060600 / HD / NICHD NIH HHS / United States
T32 HD060600-02 / HD / NICHD NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065